Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Corbus Pharmaceuticals I...

    NASDAQ: CRBP · Real-Time Price · USD
    8.31
    -0.43 (-4.92%)
    At close: Jun 17, 2025, 3:59 PM
    8.41
    1.20%
    After-hours: Jun 17, 2025, 07:55 PM EDT

    Corbus Pharmaceuticals Statistics

    Share Statistics

    Corbus Pharmaceuticals has 12.24M shares outstanding. The number of shares has increased by 14.46% in one year.

    Shares Outstanding

    n/a
    		 12.24M

    Shares Change (YoY)

    n/a
    		 14.46%

    Shares Change (QoQ)

    n/a
    		 0.43%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 10.7M

    Failed to Deliver (FTD) Shares

    n/a
    		 8,629

    FTD / Avg. Volume

    n/a
    		 5.2%

    Short Selling Information

    The latest short interest is 1.83M, so 14.97% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.83M

    Short % of Shares Out

    n/a
    		 14.97%

    Short % of Float

    n/a
    		 18.65%

    Short Ratio (days to cover)

    n/a
    		 16.48

    Valuation Ratios

    The PE ratio is -3.2 and the forward PE ratio is -1.9. Corbus Pharmaceuticals's PEG ratio is 0.05.

    PE Ratio

    n/a
    		 -3.2

    Forward PE

    n/a
    		 -1.9

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.8

    PB Ratio

    n/a
    		 0.9

    P/FCF Ratio

    n/a
    		 -3.08

    PEG Ratio

    n/a
    		 0.05
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Corbus Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 12.94, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 12.94

    Quick Ratio

    n/a
    		 12.94

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.09

    Debt / FCF

    n/a
    		 -0.08

    Interest Coverage

    n/a
    		 -26.03

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,436,035.71

    Employee Count

    n/a
    		 28

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -80.37% in the last 52 weeks. The beta is 3.12, so Corbus Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 3.12

    52-Week Price Change

    n/a
    		 -80.37%

    50-Day Moving Average

    n/a
    		 7.27

    200-Day Moving Average

    n/a
    		 14.92

    Relative Strength Index (RSI)

    n/a
    		 59.91

    Average Volume (20 Days)

    n/a
    		 165,952

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -48.72M

    Net Income

    n/a
    		 -40.21M

    EBITDA

    n/a
    		 -37.74M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -3.68
    Full Income Statement

    Balance Sheet

    The company has 17.2M in cash and 3.24M in debt, giving a net cash position of 13.96M.

    Cash & Cash Equivalents

    n/a
    		 17.2M

    Total Debt

    n/a
    		 3.24M

    Net Cash

    n/a
    		 13.96M

    Retained Earnings

    n/a
    		 -476.89M

    Total Assets

    n/a
    		 139.93M

    Working Capital

    n/a
    		 125.74M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -41.79M and capital expenditures 0, giving a free cash flow of -41.79M.

    Operating Cash Flow

    n/a
    		 -41.79M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -41.79M

    FCF Per Share

    n/a
    		 -3.83
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CRBP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CRBP is $52, which is 499.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $52

    Price Target Difference

    n/a
    		 499.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Feb 14, 2023. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 Feb 14, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 -0.88

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist